We are live on ! Find out more
LCM

Lynwood Capital Management Portfolio holdings

AUM $16.9M
1-Year Est. Return 19.31%
This Fund
S&P 500
This Quarter Est. Return
+2.2%
1 Year Est. Return
-19.31%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$83.1M
AUM Growth
-$8.46M
Cap. Flow
-$7.26M
Cap. Flow %
-8.73%
Top 10 Hldgs %
36.24%
Holding
169
New
23
Increased
9
Reduced
18
Closed
38

Top Buys

Rank Stock Value
1
XFOR icon
X4 Pharmaceuticals
XFOR
+$3.4M
2
PYPL icon
PayPal
PYPL
+$3.2M
3
BCTX
Briacell Therapeutics
BCTX
+$1.87M
4
ATCO
Atlas Corp.
ATCO
+$1.54M
5
EOSE icon
Eos Energy Enterprises
EOSE
+$1.46M

Top Sells

Rank Stock Value
1
GDXJ icon
VanEck Junior Gold Miners ETF
GDXJ
+$2.95M
2
ADBE icon
Adobe
ADBE
+$2.75M
3
LAAA
Lakeshore Acquisition I Corp. Ordinary Shares
LAAA
+$2.68M
4
CCXI
ChemoCentryx, Inc.
CCXI
+$2.58M
5
SNOW icon
Snowflake
SNOW
+$2.55M

Sector Composition

Rank Sector Weight
1 Financials 44.44%
2 Healthcare 15.83%
3 Industrials 10.35%
4 Technology 7.08%
5 Materials 5.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGFY
151
DELISTED
Signify Health, Inc.
SGFY
– –
-20,000
Closed -$583K
DTRTW
152
DELISTED
DTRT Health Acquisition Corp. Warrant
DTRTW
– –
-16,205
Closed -$3K
DTRT
153
DELISTED
DTRT Health Acquisition Corp. Class A Common Stock
DTRT
– –
-59,770
Closed -$607K
IGAC
154
DELISTED
IG Acquisition Corp. Class A Common Stock
IGAC
– –
-126,339
Closed -$1.26M
COVA
155
DELISTED
COVA Acquisition Corp. Class A Ordinary Share
COVA
– –
-25,000
Closed -$249K
OSTR
156
DELISTED
Oyster Enterprises Acquisition Corp. Class A Common Stock
OSTR
– –
-79,095
Closed -$781K
GTPA
157
DELISTED
Gores Technology Partners, Inc. Class A Common Stock
GTPA
– –
-5,000
Closed -$49K
GTPB
158
DELISTED
Gores Technology Partners II, Inc. Class A Common
GTPB
– –
-10,000
Closed -$98K
MACC
159
DELISTED
Mission Advancement Corp.
MACC
– –
-35,000
Closed -$344K
LAAA
160
DELISTED
Lakeshore Acquisition I Corp. Ordinary Shares
LAAA
– –
-266,350
Closed -$2.68M
REVH
161
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
– –
-5,000
Closed -$49K
ACII
162
DELISTED
Atlas Crest Investment Corp. II
ACII
– –
-25,840
Closed -$255K
ZEN
163
DELISTED
ZENDESK INC
ZEN
– –
-10,000
Closed -$761K
GAPA
164
DELISTED
G&P Acquisition Corp.
GAPA
– –
-68,647
Closed -$686K
HTAQ
165
DELISTED
Hunt Companies Acquisition Corp. I
HTAQ
– –
-20,400
Closed -$207K
ENPC
166
DELISTED
Executive Network Partnering Corporation
ENPC
– –
-149,960
Closed -$1.5M
CCXI
167
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-50,000
Closed -$2.58M
TGA
168
DELISTED
Transglobe Energy Corp
TGA
– –
-150,000
Closed -$402K
VYGG
169
DELISTED
Vy Global Growth
VYGG
– –
-100,360
Closed -$1.01M
3 4 5 6
7

Similar funds

PA
Pantechnicon Advisors London, United Kingdom $18.4M AUM 26.45% 1-Year Est. Return
PML
Prime Movers Lab Jackson, Wyoming $13.5M AUM 0% 1-Year Est. Return
OPPTF
OPSEU Pension Plan Trust Fund Toronto, Ontario, Canada $22.4M AUM 25.54% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
SCP
Syntal Capital Partners Midland, Texas $10M AUM 35.51% 1-Year Est. Return
NCM
Newfoundland Capital Management Sao Paulo, Brazil $9.47M AUM 21.24% 1-Year Est. Return
MA
Macellum Advisors New York $7.23M AUM 23.78% 1-Year Est. Return
OMC
Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return

Lynwood Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Lynwood Capital Management held 169 positions worth $83.1M, down 9.2% from $91.6M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Lynwood Capital Management withdrew a net $7.26M in Q4 2022, closing 38 positions and reducing 18 holdings. Its most notable exit was VanEck Junior Gold Miners ETF, an estimated $2.95M position sold in full.

By sector, the portfolio is most concentrated in Financials at 44% of assets, down from 48% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Lynwood Capital Management opened a new position in X4 Pharmaceuticals worth $2.14M.

  • Lynwood Capital Management's largest Q4 2022 buy was X4 Pharmaceuticals: 71,837 shares worth $2.14M.
  • Lynwood Capital Management added most to Briacell Therapeutics in Q4 2022, an estimated $1.87M increase.
  • Lynwood Capital Management's biggest Q4 2022 reduction was Mountain & Co. I Acquisition Corp. Class A Ordinary Shares, cutting an estimated $464K.
  • Lynwood Capital Management fully exited VanEck Junior Gold Miners ETF in Q4 2022, selling an estimated $2.95M.
  • Lynwood Capital Management's ten largest holdings make up 36% of its $83.1M portfolio in Q4 2022.
  • Lynwood Capital Management opened 23 new positions and closed 38 in Q4 2022.
  • Lynwood Capital Management's portfolio value fell 9.2% quarter-over-quarter to $83.1M.

Based on Lynwood Capital Management's 13F filing for Q4 2022, filed 7 Feb 2023.